News | May 15, 2023
Medico Remedies to foray into ointment manufacturing segment
The facility will have a capacity to manufacture upto 3 million tubes monthly
The facility will have a capacity to manufacture upto 3 million tubes monthly
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The collaboration between CORONA and Ferring will cater to patients across India
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
The appointment is effective from May 01, 2023 for five years
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Subscribe To Our Newsletter & Stay Updated
